BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38650412)

  • 1. [Modern view on the problem of diagnostics of renal angiomioadenomatous tumor].
    Osmanov Y I; Kogan E A; Gadzhieva Z K; Radenska-Lopovok S G; Prochenko D D
    Urologiia; 2024 Mar; (1):92-95. PubMed ID: 38650412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological and molecular portrait hybrid renal tumors].
    Osmanov YI; Kogan EA; Gadzhieva ZK; Prochenko DD
    Urologiia; 2023 Sep; (4):113-116. PubMed ID: 37850290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
    Hes O; Compérat EM; Rioux-Leclercq N
    Ann Diagn Pathol; 2016 Apr; 21():59-64. PubMed ID: 26897641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
    Deml KF; Schildhaus HU; Compérat E; von Teichman A; Storz M; Schraml P; Bonventre JV; Fend F; Fleige B; Nerlich A; Gabbert HE; GaBler N; Grobholz R; Hailemariam S; Hinze R; Knüchel R; Lhermitte B; Nesi G; Rüdiger T; Sauter G; Moch H
    Am J Surg Pathol; 2015 Jul; 39(7):889-901. PubMed ID: 25970683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal angiomyoadenomatous tumor (RAT): a rare distinct entity with diagnostic challenges-a case report.
    Majumder A; Phulware RH; Ahuja A; Singla A; Kumar P
    J Egypt Natl Canc Inst; 2021 Jan; 33(1):1. PubMed ID: 33415591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
    Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity.
    Michal M; Hes O; Nemcova J; Sima R; Kuroda N; Bulimbasic S; Franco M; Sakaida N; Danis D; Kazakov DV; Ohe C; Hora M
    Virchows Arch; 2009 Jan; 454(1):89-99. PubMed ID: 19020896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process.
    Petersson F; Branzovsky J; Martinek P; Korabecna M; Kruslin B; Hora M; Peckova K; Bauleth K; Pivovarcikova K; Michal M; Svajdler M; Sperga M; Bulimbasic S; Leroy X; Rychly B; Trivunic S; Kokoskova B; Rotterova P; Podhola M; Suster S; Hes O
    Virchows Arch; 2014 Jul; 465(1):89-96. PubMed ID: 24838683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
    Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
    Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal angiomyoadenomatous tumor.
    Singh C; Kendi AT; Manivel JC; Pambuccian SE
    Ann Diagn Pathol; 2012 Dec; 16(6):470-6. PubMed ID: 22534244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade renal carcinoma with histologic features overlapping with renal angiomyoadenomatous tumor and featuring polysomy 7 and 17 and a mutation in the von Hippel-Lindau gene: report of a hybrid tumor and a few comments on renal angiomyoadenomatous tumor and papillary renal tumors with clear cells.
    Petersson F; Yan B; Huang J; Thamboo TP; Bing TK; Consigliere DT
    Ann Diagn Pathol; 2011 Jun; 15(3):213-6. PubMed ID: 21396864
    [No Abstract]   [Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma with focal renal angiomyoadenomatous tumor-like area.
    Kuroda N; Hosokawa T; Michal M; Hes O; Sima R; Ohe C; Lee GH
    Ann Diagn Pathol; 2011 Jun; 15(3):202-6. PubMed ID: 20952290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinomas with a mesenchymal stromal component: what do we know so far?
    Williamson SR
    Pathology; 2019 Aug; 51(5):453-462. PubMed ID: 31266596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity.
    Verine J
    Virchows Arch; 2009 Apr; 454(4):479-80. PubMed ID: 19205727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.